Biomedical Papers: Fulltext search in archive

Biomedical Papers Award

This year, winner of Biomedical Papers Award is the paper “Is ultra low-dose CT with tin filtration useful for examination of SI joints? Can it replace X-ray in diagnostics of sacroiliitis?” Korcakova E. et al. (Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Mar;166(1):77-83. doi: 10.5507/bp.2021.008.)

The Current IF for 2024 is 0.7
5 -Year IF for 2024 is 1.1
Article influence score is 0.266
Scopus CiteScore for 2024 is 2.0
Scimago JR 2024 is 0.315
Scopus SNIP 2024 is 0.413

News/Notice to authors – a Graphical Abstract: Authors are requested to include a Graphical Abstract with their manuscript. Graphical Abstracts are required for Original research articles and Review articles. The journal provides the Graphical Abstract Templates which are recommended to use. A Graphical Abstract is a visual representation or summary of the main findings or key points of a research paper. This should allow readers to quickly grasp the essential content and main conclusions before reading the article. For more details see Instruction to Authors.

Reviewers
For Biomedical Papers.
January - December 2024
The editors and the authors of the papers submitted to the Journal are grateful for the help of our reviewers.
More information

Information For Authors
Manuscripts should be written in good and clear English. Please have your text proofread by a native English speaker before you submit it for consideration.
If you need assistance with translation/manuscript preparation in English, suitable for international journals before submission for review, please contact the proof reader
Alexander Oulton
(druides@protonmail.com)

The Current IF for 2024 is 0.7
5 -Year IF for 2024 is 1.1
Article influence score is 0.266
Scopus CiteScore for 2024 is 2.0
Scimago JR 2024 is 0.315
Scopus SNIP 2024 is 0.413

FEE NOTIFICATION
FROM 1^st MARCH 2022:
The Editorial Board would like to remind submitting authors that Biomedical Papers is a publication of Palacký University and is in no way funded by the pharmaceutical industry.
For this reason, from the 1^st March 2022 the fee of 13.000 Czech crowns or 600 EUR (plus VAT or local taxes where applicable) will apply to all manuscripts accepted for publication. Accepted manuscripts will not proceed further without receipt of payment. Thank you for your understanding.
Please note, however, reviews, minireviews, commentaries and Letters to the Editor will remain free of charge.